These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 31813210)
21. Mucopolysaccharidosis type II with inguinal hernia. Rayamajhi A; Pokharel PJ; Chapagain R; Rayamajhi AK J Nepal Health Res Counc; 2013 Sep; 11(25):293-5. PubMed ID: 24908534 [TBL] [Abstract][Full Text] [Related]
22. Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7 years follow-up. Barth AL; de Magalhães TSPC; Reis ABR; de Oliveira ML; Scalco FB; Cavalcanti NC; Silva DSE; Torres DA; Costa AAP; Bonfim C; Giugliani R; Llerena JC; Horovitz DDG Mol Genet Metab Rep; 2017 Sep; 12():62-68. PubMed ID: 28649514 [TBL] [Abstract][Full Text] [Related]
23. Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012. Lin HY; Chuang CK; Huang YH; Tu RY; Lin FJ; Lin SJ; Chiu PC; Niu DM; Tsai FJ; Hwu WL; Chien YH; Lin JL; Chou YY; Tsai WH; Chang TM; Lin SP Orphanet J Rare Dis; 2016 Jun; 11(1):85. PubMed ID: 27349225 [TBL] [Abstract][Full Text] [Related]
24. [Mucopolysaccharidosis. A case report of Morquio's type-A disease (MPS IV-A)]. Pagni L; Bartolozzi L; Giacchetti D Minerva Stomatol; 1992 Nov; 41(11):527-33. PubMed ID: 1294876 [TBL] [Abstract][Full Text] [Related]
25. Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial. Okuyama T; Eto Y; Sakai N; Minami K; Yamamoto T; Sonoda H; Yamaoka M; Tachibana K; Hirato T; Sato Y Mol Ther; 2019 Feb; 27(2):456-464. PubMed ID: 30595526 [TBL] [Abstract][Full Text] [Related]
26. Detection of mucopolysaccharidosis type II by measurement of iduronate-2-sulfatase in dried blood spots and plasma samples. Dean CJ; Bockmann MR; Hopwood JJ; Brooks DA; Meikle PJ Clin Chem; 2006 Apr; 52(4):643-9. PubMed ID: 16497940 [TBL] [Abstract][Full Text] [Related]
27. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl. Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699 [TBL] [Abstract][Full Text] [Related]
28. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype. Scott HS; Litjens T; Hopwood JJ; Morris CP Hum Mutat; 1992; 1(2):103-8. PubMed ID: 1301196 [TBL] [Abstract][Full Text] [Related]
29. Genetic analysis of 17 children with Hunter syndrome: identification and functional characterization of four novel mutations in the iduronate-2-sulfatase gene. Chistiakov DA; Kuzenkova LM; Savost'anov KV; Gevorkyan AK; Pushkov AA; Nikitin AG; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Namazova-Baranova LS; Baranov AA J Genet Genomics; 2014 Apr; 41(4):197-203. PubMed ID: 24780617 [TBL] [Abstract][Full Text] [Related]
30. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers. Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701 [TBL] [Abstract][Full Text] [Related]
31. First specific preimplantation genetic diagnosis for ornithine transcarbamylase deficiency. Ray PF; Gigarel N; Bonnefont JP; Attié T; Hamamah S; Frydman N; Vekemans M; Frydman R; Munnich A Prenat Diagn; 2000 Dec; 20(13):1048-54. PubMed ID: 11180228 [TBL] [Abstract][Full Text] [Related]
32. A rare case of mucopolysaccharidosis: hunter syndrome. Anekar J; C DN; A C R; N C S; Nappalli D J Clin Diagn Res; 2015 Apr; 9(4):ZD23-6. PubMed ID: 26023658 [TBL] [Abstract][Full Text] [Related]
33. Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II. Gleitz HF; O'Leary C; Holley RJ; Bigger BW PLoS One; 2017; 12(2):e0172435. PubMed ID: 28207863 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in Mucopolysaccharidosis Type II: A Case Series. Selvanathan A; Ellaway C; Wilson C; Owens P; Shaw PJ; Bhattacharya K JIMD Rep; 2018; 41():81-89. PubMed ID: 29671225 [TBL] [Abstract][Full Text] [Related]
36. Challenges in the Management of Mucopolysaccharidosis Type II (Hunter's Syndrome) in a Developing Country: a Case Report. Rasheeedah I; Patrick O; Abdullateef A; Mohammed A; Sherifat K; Gbadebo I Ethiop J Health Sci; 2015 Jul; 25(3):279-82. PubMed ID: 26633932 [TBL] [Abstract][Full Text] [Related]
37. Recombinant human iduronate-2-sulphatase: correction of mucopolysaccharidosis-type II fibroblasts and characterization of the purified enzyme. Bielicki J; Hopwood JJ; Wilson PJ; Anson DS Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):241-6. PubMed ID: 8424762 [TBL] [Abstract][Full Text] [Related]
38. The First Reported Case of Hyperreninemic Hypoaldosteronism Due to Mucopolysaccharidosis Disorder. Gayed A; Schott VA; Meltzer L Cureus; 2020 Jun; 12(6):e8487. PubMed ID: 32656005 [TBL] [Abstract][Full Text] [Related]
39. [Detection of two novel mutations of iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II]. Dou W; Peng C; Zheng JK; Gu XF Yi Chuan; 2007 Jan; 29(1):37-40. PubMed ID: 17284421 [TBL] [Abstract][Full Text] [Related]
40. Cochlear Implantation via the Transmeatal Approach in an Adolescent with Hunter Syndrome-Type II Mucopolysaccharidosis. Kim H; An JY; Choo OS; Jang JH; Park HY; Choung YH J Audiol Otol; 2021 Jan; 25(1):49-54. PubMed ID: 31813213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]